Drugs News and Research

RSS

Researchers discover potential treatment approach for advanced uveal melanoma

An international team of researchers led by University College Dublin (UCD) have uncovered a potential treatment approach for advanced uveal melanoma (UM), a type of cancer that effects the eye.

19 May 2022

Islet cell transplant program offers an effective treatment for patients with hard-to-control Type 1 diabetes

After 20 years of perfecting their technique, the team behind the largest islet cell transplant program in the world reports the procedure is a safe, reliable and life-changing treatment for people with hard-to-control diabetes.

19 May 2022

Rapidly growing nanotechnology firm launches new identity as MIP Discovery

MIP Diagnostics, a leading UK nanotechnology firm has today rebranded to MIP Discovery as the business continues its expansion within the healthcare sector.

From MIP Discovery 19 May 2022

In-depth characterization of the BA.2 versus BA.1 variant

In a recent study published in the journal Nature, researchers evaluated the pathogenicity and infectivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.2 variant in hamsters and mice.

19 May 2022

Researchers examine link between long-term use of blood pressure drugs and breast cancer risk

Curtin University researchers will examine if the long-term use of a popular blood pressure medication increased the risk of breast cancer in almost 200,000 women as part of a new project supported by the Federal Government.

19 May 2022

Evaluating efficacy of SARS-CoV-2 antivirals in a mouse model

In a recent study posted to the bioRxiv* pre-print server, researchers from Belgium evaluated the efficacy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antiviral drugs in a severe combined immunodeficient (SCID) mouse model.

18 May 2022

A review on the hallmarks of cancer and aging

Dr. Mikhail Blagosklonny published his new review paper in Aging (Aging-US) Volume 14, Issue 9, entitled, "Hallmarks of cancer and hallmarks of aging."

18 May 2022

Two Rutgers engineers create analytical tool to accelerate the production of biologic drugs

Two Rutgers engineers specializing in the process of making drugs derived from living organisms have created an analytical tool they expect will accelerate the discovery and production of biologic drugs that are often at the cutting edge of biomedical research.

18 May 2022

The impact of NSAIDs on COVID-19 severity

Researchers examine potential correlations between NSAID use and COVID-19 severity.

18 May 2022

Study identifies multiple barriers faced by family physicians while providing abortion services

What prevents family medicine physicians from providing medical abortions for patients who need them?

18 May 2022

NIH awards $577 million to establish AViDD Centers for Pathogens of Pandemic Concern

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded approximately $577 million to establish nine Antiviral Drug Discovery (AViDD) Centers for Pathogens of Pandemic Concern.

18 May 2022

Treatment with imatinib results in lower mortality rates for patients with severe COVID-19

Patients with severe COVID-19 who were given imatinib had lower mortality rates at 90-day follow-up, according to research published at the ATS 2022 international conference.

18 May 2022

Developing innovative approaches to combat urinary tract infections

The German government is providing about 2.4 million Euros for a new research group in infectious diseases at JMU Würzburg.

18 May 2022

High-risk prescribing practices associated with increased risk of disability among older adults

For many, good health and longevity is only achievable with the help of prescription drugs. However, researchers in Japan have recently identified that some "high-risk" prescribing practices may be a cause for concern among older adults.

18 May 2022

First patient dosed in Phase 1 clinical trial evaluating the safety of CF33-hNIS against solid tumors

Imugene Limited, a clinical stage immuno-oncology company, and City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient was dosed in a Phase 1 clinical trial evaluating the safety of novel cancer-killing virus CF33-hNIS VAXINIA when used in people with advanced solid tumors.

18 May 2022

Cannabidiol for Parkinson's disease symptom management

Scientists have published a review study in the Journal for Nurse Practitioners that has focussed on various aspects of the use of cannabidiol in Parkinson's.

17 May 2022

Polypharmacy can lead to harmful drug interactions, especially among cancer patients

Here's a scenario so common that it applies to nearly 92 percent of older adults with cancer: An individual comes in for treatment and reports taking several medications that might include a drug for high blood pressure or heart disease, an antidepressant, or something for diabetes.

17 May 2022

Experimental drug more effective than existing FDA-approved medications for ALS

New research on the experimental drug, NU-9, invented and developed by two Northwestern University scientists to treat ALS (amyotrophic lateral sclerosis), shows it is more effective than existing FDA-approved drugs for the disease.

17 May 2022

Study reveals psychological benefits of statins

Statins have been hailed as a wonder drug; the cholesterol-lowering drugs have been prescribed to tens of millions of people since their approval in the late 1980s to prevent heart attack and stroke.

17 May 2022

Acoustic holograms enable efficient, selective opening of the blood brain barrier

The holograms designed by the team of researchers from UPV and CSIC allow the opening of the blood brain barrier selectively, efficiently and in a highly focused manner, facilitating the administration of therapeutic drugs to treat pathologies that affect the central nervous system.

17 May 2022

Drugs News and Research

Researchers discover potential treatment approach for advanced uveal melanoma

Islet cell transplant program offers an effective treatment for patients with hard-to-control Type 1 diabetes

Rapidly growing nanotechnology firm launches new identity as MIP Discovery

In-depth characterization of the BA.2 versus BA.1 variant

Researchers examine link between long-term use of blood pressure drugs and breast cancer risk

Evaluating efficacy of SARS-CoV-2 antivirals in a mouse model

A review on the hallmarks of cancer and aging

Two Rutgers engineers create analytical tool to accelerate the production of biologic drugs

The impact of NSAIDs on COVID-19 severity

Study identifies multiple barriers faced by family physicians while providing abortion services

NIH awards $577 million to establish AViDD Centers for Pathogens of Pandemic Concern

Treatment with imatinib results in lower mortality rates for patients with severe COVID-19

Developing innovative approaches to combat urinary tract infections

High-risk prescribing practices associated with increased risk of disability among older adults

First patient dosed in Phase 1 clinical trial evaluating the safety of CF33-hNIS against solid tumors

Cannabidiol for Parkinson's disease symptom management

Polypharmacy can lead to harmful drug interactions, especially among cancer patients

Experimental drug more effective than existing FDA-approved medications for ALS

Study reveals psychological benefits of statins

Acoustic holograms enable efficient, selective opening of the blood brain barrier

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News